Maintaining Exercise During Pandemic Aids Prenatal Mental Health
Findings based on an online survey of more than 1,800 pregnant women
Findings based on an online survey of more than 1,800 pregnant women
Nine months into the pandemic, it’s become clear that the effects of the disease caused by SARS-CoV-2 can last beyond the acute illness. Among COVID-19 patients 18 to 35 years old who were previously in good health, as many as 20% experience prolonged symptoms, according to the World Health Organization. Complaints among so-called long-haulers include…
Researchers sought to determine the acceptability and preliminary effectiveness of Mind-Body Skills Groups (MBSGs) as a treatment for depressed adolescents in primary care.
Using phenotypic and genomic data from over 100,000 UK Biobank participants, study authors sought to systematically screen and validate a wide range of potential modifiable factors for depression.
Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
SSRI use after intracerebral hemorrhage may resolve depression symptoms, but also increases patients’ risk for recurrent stroke.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
The 510(k) clearance allows for modification of the labeling of the previously authorized pharmacogenetics report.
As an increasing number of patients are seeking professional treatment for attachment disorders, clinicians need to stay up to date on the latest developments to mitigate the far-reaching effects of these conditions.
Depression and anxiety exhibited in COVID-19 patients may be a sign that the virus impacts the central nervous system.